CompletedNCT03166098
Brain Myelination and Cognition in Psychosis-Spectrum Conditions
About this title
Read the official source — NCT03166098Observational studyAges 18–30United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 30 years.
- Listed locations
- New YorkSee all locations and recruitment
Study information
Study start dateStarted: July 5, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 139
- Sponsor
- NYU Langone Health
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Diagnostic test
- Locations
- United States
- Age range
- From 18 Years to 30 Years
- Official registry ID
- NCT03166098
- Official title
Show the full official title
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is NYU Langone Health.
Who was this study for?
Listed age limits: 18 years to 30 years.
